216 related articles for article (PubMed ID: 31937855)
21. Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.
Messerli FH; Soria F
Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():557-63. PubMed ID: 7841089
[TBL] [Abstract][Full Text] [Related]
22. Hypertension, left ventricular hypertrophy, and sudden death.
Tin LL; Beevers DG; Lip GY
Curr Cardiol Rep; 2002 Nov; 4(6):449-57. PubMed ID: 12379162
[TBL] [Abstract][Full Text] [Related]
23. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
[TBL] [Abstract][Full Text] [Related]
24. Effects of antihypertensive agents on the left ventricle: clinical implications.
Díez J; González A; López B; Ravassa S; Fortuño MA
Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
[TBL] [Abstract][Full Text] [Related]
25. Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death.
Messerli FH; Grodzicki T
Eur Heart J; 1992 Sep; 13 Suppl D():66-9. PubMed ID: 1396863
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
[TBL] [Abstract][Full Text] [Related]
27. Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
Okin PM; Bang CN; Wachtell K; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):243-51. PubMed ID: 23403268
[TBL] [Abstract][Full Text] [Related]
28. Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia.
Koracevic G; Mićić S; Stojanovic M; Bozinovic N; Simic D; Lović D; Krstic N; Tomašević RJ
Curr Vasc Pharmacol; 2023; 21(2):81-90. PubMed ID: 36722475
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals: A Cochrane review summary.
Visvanathan V
Int J Nurs Stud; 2018 Jun; 82():165-166. PubMed ID: 29031883
[No Abstract] [Full Text] [Related]
30. Left ventricular hypertrophy and antihypertensive therapy.
Messerli FH; Oren S; Grossman E
Drugs; 1988; 35 Suppl 5():27-33. PubMed ID: 2975215
[TBL] [Abstract][Full Text] [Related]
31. Hypertensive heart disease.
Diamond JA; Phillips RA
Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
[TBL] [Abstract][Full Text] [Related]
32. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
Saadeh AM; Jones JV
J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients.
Muiesan ML; Salvetti M; Monteduro C; Bonzi B; Paini A; Viola S; Poisa P; Rizzoni D; Castellano M; Agabiti-Rosei E
Hypertension; 2004 Apr; 43(4):731-8. PubMed ID: 15007041
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular hypertrophy as a risk factor in hypertension.
Balogun MO; Dunn FG
Afr J Med Med Sci; 1996 Sep; 25(3):277-83. PubMed ID: 10457806
[TBL] [Abstract][Full Text] [Related]
35. Left ventricular hypertrophy: its prime importance as a controllable risk factor.
Weber JR
Am Heart J; 1988 Jul; 116(1 Pt 2):272-9. PubMed ID: 2969187
[TBL] [Abstract][Full Text] [Related]
36. Selection of antihypertensive therapy: cardiac and extracardiac considerations.
Messerli FH; Soria F
Cardiology; 1992; 81(4-5):316-24. PubMed ID: 1301259
[TBL] [Abstract][Full Text] [Related]
37. Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.
Hui SK; Sharma A; Docherty K; McMurray JJV; Pitt B; Dickstein K; Pfeffer MA; Girerd N; Rossignol P; Ferreira JP; Zannad F
Eur Heart J Acute Cardiovasc Care; 2021 Apr; 10(2):127-131. PubMed ID: 33620418
[TBL] [Abstract][Full Text] [Related]
38. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
Amabile G
Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
[TBL] [Abstract][Full Text] [Related]
39. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
Porthan K; Kenttä T; Niiranen TJ; Nieminen MS; Oikarinen L; Viitasalo M; Hernesniemi J; Jula AM; Salomaa V; Huikuri HV; Albert CM; Tikkanen JT
Int J Cardiol; 2019 Feb; 276():125-129. PubMed ID: 30293667
[TBL] [Abstract][Full Text] [Related]
40. Incidence and Risk Factors of Sudden Cardiac Death in End-Stage Renal Disease Patients Undergoing Hemodialysis: A Retrospective Study.
Khan MT; Hameed B; Ahmed J
Saudi J Kidney Dis Transpl; 2021; 32(4):957-966. PubMed ID: 35229792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
